Pfizer says the vaccine is 73% effective in children under five.
Pfizer notes that the omicron variant was the dominant strain when the study was conducted.
“Building on the strong safety and immunogenicity data that led to FDA authorization of our COVID-19 vaccine for children 6 months through 4 years, we are pleased to share confirmatory evidence that a full course of vaccination helps protect against symptomatic disease, particularly during a time when the Omicron BA.2 strain was predominant,” said Albert Bourla, chairman and chief executive officer of Pfizer.
Getting young children vaccinated remains a challenge. According to ABC News, only 4.8% of children under five years old have been vaccinated against COVID-19.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Myocarditis Risk Higher After COVID-19 Infection than After COVID-19 VaccinationThe risk of myocarditis is substantially higher in the 4 weeks after COVID-19 infection than after a first dose of a COVID-19 vaccine, say researchers of new study. CardioTwitter
Les mer »
Post-COVID Symptoms in Kids: Not Always Long COVIDDo kids get long COVID? Look for these unique signs and symptoms. MedTwitter
Les mer »
Pfizer COVID shots appear 73% effective in children under 5Pfizer’s COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring, the company announced Tuesday.
Les mer »
Pfizer COVID shots appear 73% effective in children under 5Pfizer's COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring, the company announced Tuesday. Vaccinations for babies, toddlers and preschoolers opened in the U.S.
Les mer »
Pfizer asks FDA to authorize updated COVID vaccine adding protection from Omicron variantsThe FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine.
Les mer »
Pfizer asks FDA to authorize updated COVID vaccine adding protection from Omicron variantsThe FDA ordered vaccine makers to tweak their shots to target BA.4 and BA.5. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine.
Les mer »